Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Skin Cancer01:30

Skin Cancer

4.3K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.3K
Cancer Survival Analysis01:21

Cancer Survival Analysis

405
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
405
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circadian disruption induces sex-specific Alzheimer's pathophysiology and immune cell reprogramming.

bioRxiv : the preprint server for biology·2026
Same author

Effect of transcript length, temperature, and lyophilization on mRNA-lipid nanoparticle stability.

Journal of pharmaceutical sciences·2026
Same author

Integrated transcriptomic and functional analyses reveal that NOX2 inhibition rewires the inflammatory landscape of macrophages.

Frontiers in immunology·2026
Same author

Probing Glycosaminoglycan-Protein Interactions: Applications of Surface Plasmon Resonance.

Biosensors·2026
Same author

Enhanced lentiviral vector recovery and separation using arginine hydrochloride with CIM QA monoliths.

Biotechnology progress·2026
Same author

From innovation to implementation: Artificial intelligence in cognitive behaviour therapy training and supervision.

Behaviour research and therapy·2026
Same journal

DARUMA: a gateway to fast and easy prediction of intrinsically disordered regions.

PeerJ. Computer science·2026
Same journal

Alzheimer's disease detection using a quantum deep neural network with Haralick feature extraction and simulated annealing optimization.

PeerJ. Computer science·2026
Same journal

Network anomaly detection using Deep Autoencoder and parallel Artificial Bee Colony algorithm-trained neural network.

PeerJ. Computer science·2026
Same journal

An anomaly detection model for multivariate time series with anomaly perception.

PeerJ. Computer science·2026
Same journal

Retraction: A wormhole attack detection method for tactical wireless sensor networks.

PeerJ. Computer science·2026
Same journal

Evaluation of mental disorder with prioritization of its type by utilizing the bipolar complex fuzzy decision-making approach based on Schweizer-Sklar prioritized aggregation operators.

PeerJ. Computer science·2026
See all related articles

Related Experiment Video

Updated: Jul 31, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.7K

Finding melanoma drugs through a probabilistic knowledge graph.

Jamie Patricia McCusker1, Michel Dumontier2, Rui Yan1

  • 1Department of Computer Science, Rensselaer Polytechnic Institute, Troy, NY, USA.

Peerj. Computer Science
|May 3, 2023
PubMed
Summary
This summary is machine-generated.

Researchers developed ReDrugS, a knowledge graph system, to identify promising drug candidates for metastatic cutaneous melanoma. This approach enhances drug discovery by integrating biological data, offering new therapeutic options for this aggressive skin cancer.

Keywords:
Drug repositioningKnowledge graphsMelanomaUncertainty reasoning

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.5K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

378

Related Experiment Videos

Last Updated: Jul 31, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.7K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.5K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

378

Area of Science:

  • Oncology
  • Bioinformatics
  • Computational Biology

Background:

  • Metastatic cutaneous melanoma is an aggressive skin cancer lacking a definitive cure.
  • Existing treatments offer limited efficacy, and identifying novel drug candidates from vast omics data is challenging.
  • Fragmented systems biology databases hinder comprehensive drug discovery efforts.

Purpose of the Study:

  • To develop an integrated, evidence-weighted knowledge graph for identifying high-quality drug candidates for melanoma.
  • To leverage systems biology and network analysis for improved drug discovery.
  • To provide a platform (ReDrugS) for generating and evaluating potential melanoma therapies.

Main Methods:

  • Constructed an evidence-weighted knowledge graph integrating drug, protein, and disease interactions.
  • Developed the ReDrugS system, accessible via API and web interface.
  • Applied probabilistic analysis to systems biology graphs to enhance drug candidate prioritization.

Main Results:

  • Generated 25 high-quality drug candidates for metastatic cutaneous melanoma.
  • Demonstrated that probabilistic graph analysis improves drug candidate quality over non-probabilistic methods.
  • Identified 4 novel therapies, with 3 previously tested in other cancers; others have clinical trial or preclinical data.

Conclusions:

  • The ReDrugS knowledge graph approach effectively identifies promising drug candidates for melanoma.
  • Probabilistic systems biology analysis offers a superior method for drug discovery in oncology.
  • This approach holds potential for advancing research and personalized medicine in cancer therapy.